Ignite Creation Date:
2024-05-05 @ 5:23 PM
Last Modification Date:
2024-10-26 @ 9:31 AM
Study NCT ID:
NCT00449111
Status:
TERMINATED
Last Update Posted:
2022-02-15
First Post:
2007-03-16
Brief Title:
An Open Label Study to Assess the Efficacy Safety and Tolerability of COZAAR Plus Losartan Potassium 50mgHydrochlorothiazide 125mg Possibly Titrated up to COZAAR Plus-F Losartan Potassium 100mgHydrochlorothiazide 25mg in Patients With Essential Hypertension 0954A-325
Sponsor:
Organon and Co
Organization:
Organon and Co
Study Overview
Official Title:
An Open Label Study to Assess the Efficacy Safety and Tolerability of COZAAR Plus Losartan Potassium 50mgHydrochlorothiazide 125mg Possibly Titrated up to COZAAR Plus-F Losartan Potassium 100mgHydrochlorothiazide 25mg in Patients With Essential Hypertension
Status:
TERMINATED
Status Verified Date:
2022-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Evaluate blood pressure after 6 weeks of treatment with COZAAR plus
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 2007_005 | None | None | None |